“…A previous report demonstrated that overexpression of most fatty acid transporters promotes CoA activity by two- to five-fold [38] . Consistently, our study also showed that SCFAs treatment resulted in significantly elevated expression of genes in the CoA-related pathway, including HMGCLL1 , HMGCS2 , CPT1A (β-oxidation), ECI2 , CRAT, and ACSF2 ( Fig.…”